Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis

GR Oates, MS Schechter - Clinics in Chest Medicine, 2023 - chestmed.theclinics.com
Cystic fibrosis (CF), the second most common lifeshortening autosomal recessive genetic
disorder in the United States, is characterized by abnormal secretions in multiple organ …

Tear down this wall: diversity and disparities in cystic fibrosis

MMC Buu, CE Milla - American journal of respiratory and critical …, 2018 - atsjournals.org
The 21st century has witnessed dramatic advances in the care for people affected by cystic
fibrosis (CF). Known for decades as a frequently lethal disease during childhood, it is …

Toward a broader understanding of cystic fibrosis epidemiology and its impact on clinical manifestations

KA McBennett, PB Davis - Clinics in Chest Medicine, 2022 - chestmed.theclinics.com
Cystic fibrosis (CF) arises from the mutation of a single gene encoding the cystic fibrosis
transmembrane conductance regulator (CFTR), 1 a chloride channel that is widely …

What Do Adults With Cystic Fibrosis Want From Their Doctors?

PR Burgel - Chest, 2022 - journal.chestnet.org
Cystic fibrosis (CF) is an autosomal recessive genetic disease caused by mutations in the
gene encoding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein …

Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies

GR Oates, MS Schechter - Expert review of respiratory medicine, 2022 - Taylor & Francis
Introduction Great variation exists in the progression and outcomes of cystic fibrosis (CF)
lung disease, due to both genetic and environmental influences. Social determinants …

The demographics of adverse outcomes in cystic fibrosis

ME McGarry, WA Williams… - Pediatric …, 2019 - Wiley Online Library
Understanding variability in cystic fibrosis (CF) health outcomes requires an understanding
of factors that go far beyond Cystic Fibrosis Transmembrane Receptor (CFTR) function …

Socioeconomic disparities in European cystic fibrosis outcomes: time to close the gap

EF McKone - European Respiratory Journal, 2024 - Eur Respiratory Soc
Extract Cystic fibrosis (CF) is one of the most common autosomal recessive genetic
conditions that causes progressive lung disease and premature death [1]. Median survival …

Unraveling the CFTR function–phenotype connection for precision treatment in cystic fibrosis

ET Zemanick, D Polineni - … journal of respiratory and critical care …, 2019 - atsjournals.org
The clinical phenotype of cystic fibrosis (CF), chronic infection, and inflammation leading to
progressive obstructive lung disease and pancreatic insufficiency is caused by absence or …

Disparities and therapeutic advances in cystic fibrosis

JB Palla - Pediatric Pulmonology, 2023 - Wiley Online Library
Cystic fibrosis (CF) has seen a multitude of therapeutic advances targeting its downstream
effects. This has led to a steady increase in survival over the past few decades. The recent …

Genetics of cystic fibrosis: clinical implications

ME Egan - Clinics in chest medicine, 2016 - chestmed.theclinics.com
Cystic fibrosis (CF) is a common life-shortening autosomal recessive genetic disorder that is
characterized by eccrine (sweat) gland dysfunction, chronic obstructive lung disease, and …